Category Public Health
Kathy Hodgkinson and Daryl Pullman propose that high risk/high recurrence genetic diseases should come under the purview of public health.
Françoise Baylis responds to the recently announced birth of the world’s first genome edited babies and raises concerns about the scientific practice and ethical accountability.
Deborah Gleeson and Ronald Labonté object to lengthening market exclusivity for biologic medicines in the United States-Mexico-Canada Agreement.
Landon J. Getz provides an update on Canadian Blood Services’ progress in updating outmoded policies on gay blood donation.
Martha Paynter supports an altruistic model of human milk donation and calls for improved regulation of human milk donation to ensure equity of access, safer milk sharing, and guard against for-profit milk banking.
Marc-André Gagnon dispels misconceptions about the benefits of private health insurance plans and argues in favour of a universal model for pharmacare.
Andrea Frydl cautions Canadians about the harms of direct-to-consumer advertising for pharmaceuticals and offers advice for health care providers and policy makers.